The Role of Perineuronal Nets in Alzheimer’s Disease: A New Target for Treatment
Alzheimer’s disease is a devastating condition that affects millions of people worldwide. The early stages of the disease are characterized by a decline in short-term memory, mood swings, disorientation, and difficulty concentrating. As the disease progresses, patients may experience the loss of social memory, which robs them of their ability to recognize familiar people.
A recent study conducted by scientists from the University of Virginia School of Medicine and Virginia Tech has shed light on the role of specialized structures called perineuronal nets in the progression of Alzheimer’s disease. These nets form a mesh-like matrix around neurons in certain brain regions, where they regulate neural plasticity and stabilize synaptic contacts between neurons.
In their study on mice, the researchers found that disruptions in perineuronal nets in the hippocampus region known as CA2 led to a loss of social memory in the mice. Despite retaining the ability to form new memories about objects, the mice were unable to remember other mice when these nets deteriorated.
These findings mirror the experiences of people with Alzheimer’s, where social memory often fades before object memory. The researchers also discovered that by using matrix metalloproteinase (MMP) inhibitors to preserve the perineuronal nets, they were able to prevent the loss of social memories in mice with Alzheimer’s.
Lead author Lata Chaunsali, a graduate student in neuroscience at UVA, stated, “In our research with mice, when we kept these brain structures safe early in life, the mice suffering from this disease were better at remembering their social interactions.”
While these findings are promising, more research is needed to validate these results and determine their applicability to humans. “Although we have drugs that can delay the loss of perineuronal nets and memory loss in disease, more research needs to be done regarding safety and effectiveness of our approach before this can be considered in humans,” said neuroscientist Harald Sontheimer.
With an estimated 55 million people living with dementia globally, and Alzheimer’s accounting for more than 60 percent of cases, the need for effective treatments is urgent. The discovery of perineuronal nets as a potential target for treatment offers hope for the future of Alzheimer’s research and treatment.
The study was published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, marking a significant step forward in our understanding of the disease.
